August 05, 2017

Bioverativ Inc (NASD:BIVV) Zacks Rank: 1-Strong Buy

$58.75 USD (As of 08/04/2017) Style : Value: Growth: Momentum: VGM:

Target Price $70.00 Price, Consensus & Surprise

52 Week High-Low $64.41 - $40.00
20 Day Average
1,624,709
Volume

Beta NA
Market Cap 6.36 B
Dividend / Div Yld $0.00 / 0.00%
Medical -
Industry
Biomed..

108 / 265 (Top

Industry Rank
41%)
Proj. EPS Growth (Q1) NA
Proj. EPS Growth (F1) NA

P/E (F1) 23.64

Last EPS Surprise 10.94%

Avg. Last 4 Surprises 7.89%

Next Report Date 11/1/2017

Earnings ESP -1.61%

Agreement Estimate Revisions (60 Days) Magnitude Consensus Estimate Trend (60 Days)

Q1 Q2 F1 F2 Q1 Q2 F1 F2
# of Analysts 2 2 2 2 Current 0.62 0.59 2.49 2.78

# of Revisions 1 1 1 1 7 Days Ago 0.62 0.59 2.49 2.78

# Up 1 1 1 1 30 Days Ago 0.60 0.58 2.42 2.64

# Down 0 0 0 0 60 Days Ago 0.57 0.53 2.33 2.64

Trend of
% Revision Agreement: 100% 100% 100% 100% Estimate
Revisions: +8.77% +11.32% +6.87% +5.30%

Industry Comparison Medical - Biomed.. | Position in Industry: 1 of 246 Industry Peers

BIVV X Industry S&P 500 HZNP IART MYGN

Hist. EPS Growth (3-5 yrs) NA 19.51% 7.16% 102.45% 6.16% -3.90%
Proj. Sales Growth (F1/F0) 23.03% 0.00% 5.19% -3.58% 13.79% 3.44%
Net Margin NA -293.48% 9.92% -21.26% 6.27% 4.26%
Return on Equity NA -58.53% 15.95% 21.51% 16.79% 10.53%
Debt/Capital NA 0.00% 41.54% 60.94% 49.23% 18.26%
P/E (F1) 24.63 25.75 18.89 20.40 25.72 22.77
Price/Sales (P/S) NA 13.12 2.50 2.01 3.65 2.18
Price/Book (P/B) 9.85 3.44 3.22 1.66 4.27 2.21
Price/Cash Flow (P/CF) NA 22.38 13.54 4.09 17.44 11.98
YTD % Price Change NA 2.43% 9.77% -23.73% 14.02% 45.53%

Description Medical > Drugs > Medical - Biomedical And Genetics

Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative
therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States.

Learn More about Zacks Rank and Style Scores